A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)
Pain in nerves, frequently involving facial SKIN, resulting from the activation the latent varicella-zoster virus (HERPESVIRUS 3, HUMAN). The two forms of the condition preceding the pain are HERPES ZOSTER OTICUS; and HERPES ZOSTER OPHTHALMICUS. Following the healing of the rashes and blisters, the pain sometimes persists.
Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
Neuralgic syndromes which feature chronic or recurrent FACIAL PAIN as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions.
The 5th and largest cranial nerve. The trigeminal nerve is a mixed motor and sensory nerve. The larger sensory part forms the ophthalmic, mandibular, and maxillary nerves which carry afferents sensitive to external or internal stimuli from the skin, muscles, and joints of the face and mouth and from the teeth. Most of these fibers originate from cells of the TRIGEMINAL GANGLION and project to the TRIGEMINAL NUCLEUS of the brain stem. The smaller motor part arises from the brain stem trigeminal motor nucleus and innervates the muscles of mastication.
Diseases of the ninth cranial (glossopharyngeal) nerve or its nuclei in the medulla. The nerve may be injured by diseases affecting the lower brain stem, floor of the posterior fossa, jugular foramen, or the nerve's extracranial course. Clinical manifestations include loss of sensation from the pharynx, decreased salivation, and syncope. Glossopharyngeal neuralgia refers to a condition that features recurrent unilateral sharp pain in the tongue, angle of the jaw, external auditory meatus and throat that may be associated with SYNCOPE. Episodes may be triggered by cough, sneeze, swallowing, or pressure on the tragus of the ear. (Adams et al., Principles of Neurology, 6th ed, p1390)
Pain associated with a damaged PUDENDAL NERVE. Clinical features may include positional pain with sitting in the perineal and genital areas, sexual dysfunction and FECAL INCONTINENCE and URINARY INCONTINENCE.
Mechanical compression of nerves or nerve roots from internal or external causes. These may result in a conduction block to nerve impulses (due to MYELIN SHEATH dysfunction) or axonal loss. The nerve and nerve sheath injuries may be caused by ISCHEMIA; INFLAMMATION; or a direct mechanical effect.
Surgical interruption of a spinal or cranial nerve root. (From Dorland, 28th ed)
An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3.
Surgery performed to relieve pressure from MICROVESSELS that are located around nerves and are causing NERVE COMPRESSION SYNDROMES.
Junction between the cerebellum and the pons.
Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
A surgical operation for the relief of pressure in a body compartment or on a body part. (From Dorland, 28th ed)
The performance of surgical procedures with the aid of a microscope.
The application, via IMPLANTED ELECTRODES, of short bursts of electrical energy in the radiofrequency range, interspersed with pauses in delivery of the current long enough to dissipate the generated heat and avoid heat-induced tissue necrosis.
Procedures using an electrically heated wire or scalpel to treat hemorrhage (e.g., bleeding ulcers) and to ablate tumors, mucosal lesions, and refractory arrhythmias. It is different from ELECTROSURGERY which is used more for cutting tissue than destroying and in which the patient is part of the electric circuit.
An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.
Part of the back and base of the CRANIUM that encloses the FORAMEN MAGNUM.
Compounds capable of relieving pain without the loss of CONSCIOUSNESS.
Recurrent clonic contraction of facial muscles, restricted to one side. It may occur as a manifestation of compressive lesions involving the seventh cranial nerve (FACIAL NERVE DISEASES), during recovery from BELL PALSY, or in association with other disorders. (From Adams et al., Principles of Neurology, 6th ed, p1378)
Virus infection of the Gasserian ganglion and its nerve branches characterized by pain and vesicular eruptions with much swelling. Ocular involvement is usually heralded by a vesicle on the tip of the nose. This area is innervated by the nasociliary nerve.
The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans.
Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.
The 9th cranial nerve. The glossopharyngeal nerve is a mixed motor and sensory nerve; it conveys somatic and autonomic efferents as well as general, special, and visceral afferents. Among the connections are motor fibers to the stylopharyngeus muscle, parasympathetic fibers to the parotid glands, general and taste afferents from the posterior third of the tongue, the nasopharynx, and the palate, and afferents from baroreceptors and CHEMORECEPTOR CELLS of the carotid sinus.
Absent or reduced sensitivity to cutaneous stimulation.
A vascular anomaly characterized by a radial or wedge-shaped arrangement of dilated VEINS draining into a larger vein in the brain, spinal cord, or the meninges. Veins in a venous angioma are surrounded by normal nervous tissue, unlike a CENTRAL NERVOUS SYSTEM CAVERNOUS HEMANGIOMA that lacks intervening nervous tissue. Drainage of venous angioma is fully integrated with the body's venous system, therefore, in most cases there is no clinical signs and rare bleeding.
Subjective cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation.
A syndrome associated with inflammation of the BRACHIAL PLEXUS. Clinical features include severe pain in the shoulder region which may be accompanied by MUSCLE WEAKNESS and loss of sensation in the upper extremity. This condition may be associated with VIRUS DISEASES; IMMUNIZATION; SURGERY; heroin use (see HEROIN DEPENDENCE); and other conditions. The term brachial neuralgia generally refers to pain associated with brachial plexus injury. (From Adams et al., Principles of Neurology, 6th ed, pp1355-6)
Diseases of the trigeminal nerve or its nuclei, which are located in the pons and medulla. The nerve is composed of three divisions: ophthalmic, maxillary, and mandibular, which provide sensory innervation to structures of the face, sinuses, and portions of the cranial vault. The mandibular nerve also innervates muscles of mastication. Clinical features include loss of facial and intra-oral sensation and weakness of jaw closure. Common conditions affecting the nerve include brain stem ischemia, INFRATENTORIAL NEOPLASMS, and TRIGEMINAL NEURALGIA.
The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.
Twelve pairs of nerves that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers.
A subjective psychometric response scale used to measure distinct behavioral or physiological phenomena based on linear numerical gradient or yes/no alternatives.
Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing. It is sometimes associated with various dental treatments.
The 31 paired peripheral nerves formed by the union of the dorsal and ventral spinal roots from each spinal cord segment. The spinal nerve plexuses and the spinal roots are also included.
A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed)
Persistent pain that is refractory to some or all forms of treatment.
The semilunar-shaped ganglion containing the cells of origin of most of the sensory fibers of the trigeminal nerve. It is situated within the dural cleft on the cerebral surface of the petrous portion of the temporal bone and gives off the ophthalmic, maxillary, and part of the mandibular nerves.
A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.
INFARCTION of the dorsolateral aspect of MEDULLA OBLONGATA in the BRAIN STEM. It is caused by occlusion of the VERTEBRAL ARTERY and/or the posterior inferior cerebellar artery. Clinical manifestations vary with the size of infarction, but may include loss of pain and temperature sensation in the ipsilateral face and contralateral body below the chin; ipsilateral HORNER SYNDROME; ipsilateral ATAXIA; DYSARTHRIA; VERTIGO; nausea, hiccup; dysphagia; and VOCAL CORD PARALYSIS. (From Adams et al., Principles of Neurology, 6th ed, p801)
An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.
Drugs that act on neuronal sensory receptors resulting in an increase, decrease, or modification of afferent nerve activity. (From Smith and Reynard, Textbook of Pharmacology, 1991, p367)
A radiological stereotactic technique developed for cutting or destroying tissue by high doses of radiation in place of surgical incisions. It was originally developed for neurosurgery on structures in the brain and its use gradually spread to radiation surgery on extracranial structures as well. The usual rigid needles or probes of stereotactic surgery are replaced with beams of ionizing radiation directed toward a target so as to achieve local tissue destruction.
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.
Nuclei of the trigeminal nerve situated in the brain stem. They include the nucleus of the spinal trigeminal tract (TRIGEMINAL NUCLEUS, SPINAL), the principal sensory nucleus, the mesencephalic nucleus, and the motor nucleus.
A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.
A purine that is an isomer of ADENINE (6-aminopurine).
Process in which a patient is induced into a trance-like state in order to relieve anxiety during a dental procedure.
An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
Surgery performed on the nervous system or its parts.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia. (1/1061)

We investigated the effects of OT-7100, a novel analgesic compound (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimidi ne), on prostaglandin E2 biosynthesis in vitro, acute hyperalgesia induced by yeast and substance P in rats and hyperalgesia in rats with a chronic constriction injury to the sciatic nerve (Bennett model), which is a model for peripheral neuropathic pain. OT-7100 did not inhibit prostaglandin E2 biosynthesis at 10(-8)-10(-4) M. Single oral doses of 3 and 10 mg/kg OT-7100 were effective on the hyperalgesia induced by yeast. Single oral doses of 0.1, 0.3, 1 and 3 mg/kg OT-7100 were effective on the hyperalgesia induced by substance P in which indomethacin had no effect. Repeated oral administration of OT-7100 (10 and 30 mg/kg) was effective in normalizing the mechanical nociceptive threshold in the injured paw without affecting the nociceptive threshold in the uninjured paw in the Bennett model. Indomethacin had no effect in this model. While amitriptyline (10 and 30 mg/kg) and clonazepam (3 and 10 mg/kg) significantly normalized the nociceptive threshold in the injured paw, they also increased the nociceptive threshold in the uninjured paw. These results suggest that OT-7100 is a new type of analgesic with the effect of normalizing the nociceptive threshold in peripheral neuropathic hyperalgesia.  (+info)

Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. (2/1061)

There is growing evidence that nerve growth factor (NGF) may function as a mediator of persistent pain states. We have identified a novel nonpeptidic molecule, ALE-0540, that inhibits the binding of NGF to tyrosine kinase (Trk) A or both p75 and TrkA (IC50 5.88 +/- 1. 87 microM, 3.72 +/- 1.3 microM, respectively), as well as signal transduction and biological responses mediated by TrkA receptors. ALE-0540 was tested in models of neuropathic pain and thermally-induced inflammatory pain, using two routes of administration, a systemic i.p. and a spinal intrathecal (i.th.) route. Morphine was also tested for comparison in the antiallodynia model using mechanical stimuli. We show that either i.p. or i.th. administration of ALE-0540 in rats produced antiallodynia in the L5/L6 ligation model of neuropathic pain. The calculated A50 values (and 95% confidence intervals) for ALE-0540 administered i.p. and i. th. were 38 (17.5-83) mg/kg and 34.6 (17.3-69.4) microgram, respectively. ALE-0540 given i.th., at doses of 30 and 60 microgram, also blocked tactile allodynia in the thermal sensitization model. Although morphine displayed greater potency [A50 value of 7.1 (5.6-8. 8) mg/kg] than ALE-0540 in anti-allodynic effect when given i.p. to L5/L6-ligated rats, it was not active when administered i.th. These data suggest that a blockade of NGF bioactivity using a NGF receptor antagonist is capable of blocking neuropathic and inflammatory pain and further support the hypothesis that NGF is involved in signaling pathways associated with these pain states. ALE-0540 represents a nonpeptidic small molecule which can be used to examine mechanisms leading to the development of agents for the treatment of pain.  (+info)

Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. (3/1061)

Compelling evidence has accumulated over the last several years from our laboratory, as well as others, indicating that central hyperactive states resulting from neuronal plastic changes within the spinal cord play a critical role in hyperalgesia associated with nerve injury and inflammation. In our laboratory, chronic constriction injury of the common sciatic nerve, a rat model of neuropathic pain, has been shown to result in activation of central nervous system excitatory amino acid receptors and subsequent intracellular cascades including protein kinase C translocation and activation, nitric oxide production, and nitric oxide-activated poly(ADP ribose) synthetase activation. Similar cellular mechanisms also have been implicated in the development of tolerance to the analgesic effects of morphine. A recently observed phenomenon, the development of "dark neurons," is associated with both chronic constriction injury and morphine tolerance. A site of action involved in both hyperalgesia and morphine tolerance is in the superficial laminae of the spinal cord dorsal horn. These observations suggest that hyperalgesia and morphine tolerance may be interrelated at the level of the superficial laminae of the dorsal horn by common neural substrates that interact at the level of excitatory amino acid receptor activation and subsequent intracellular events. The demonstration of interrelationships between neural mechanisms underlying hyperalgesia and morphine tolerance may lead to a better understanding of the neurobiology of these two phenomena in particular and pain in general. This knowledge may also provide a scientific basis for improved pain management with opiate analgesics.  (+info)

Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies? (4/1061)

Painful peripheral neuropathies are precipitated by nerve injury from disease or trauma. All such injuries will be accompanied by an inflammatory reaction, a neuritis, that will mobilize the immune system. The role of the inflammation itself is difficult to determine in the presence of structural damage to the nerve. A method has been devised to produce a focal neuritis in the rat sciatic nerve that involves no more than trivial structural damage to the nerve. This experimental focal neuritis produces neuropathic pain sensations (heat- and mechano-hyperalgesia, and cold- and mechano-allodynia) in the ipsilateral hind paw. The abnormal pain sensations begin in 1-2 days and last for 4-6 days, with a subsequent return to normal. These results suggest that there is a neuroimmune interaction that occurs at the outset of nerve injury (and perhaps episodically over time in slow developing conditions like diabetic neuropathy) that produces neuropathic pain. The short duration of the phenomena suggest that they may prime the system for more slowly developing mechanisms of abnormal pain (e.g., ectopic discharge in axotomized primary afferent neurons) that underlie the chronic phase of painful neuropathy.  (+info)

Using gabapentin to treat neuropathic pain. (5/1061)

OBJECTIVE: To review use of gabapentin as an adjuvant agent to treat neuropathic pain. QUALITY OF EVIDENCE: MEDLINE was searched from 1995 to October 1998 for reports. There were approximately 20 citations. Additional articles from Pain and other medical journals were reviewed. No double-blind studies have examined gabapentin and its use as an analgesic adjuvant agent. MAIN MESSAGE: Gabapentin is an anticonvulsant medication used recently as an effective adjuvant agent for treating neuropathic pain. It is a structural analogue of gamma-aminobutyric acid (GABA), but its receptor and biochemical function remain unknown. Gabapentin has desirable pharmacokinetic properties and acceptable side effects, which simplify its use. There are very few interactions between gabapentin and other medications, and gabapentin is well tolerated. CONCLUSION: Gabapentin could be an effective adjuvant agent for many neuropathic pain states.  (+info)

Transmission of chronic nociception by spinal neurons expressing the substance P receptor. (6/1061)

Substance P receptor (SPR)-expressing spinal neurons were ablated with the selective cytotoxin substance P-saporin. Loss of these neurons resulted in a reduction of thermal hyperalgesia and mechanical allodynia associated with persistent neuropathic and inflammatory pain states. This loss appeared to be permanent. Responses to mildly painful stimuli and morphine analgesia were unaffected by this treatment. These results identify a target for treating persistent pain and suggest that the small population of SPR-expressing neurons in the dorsal horn of the spinal cord plays a pivotal role in the generation and maintenance of chronic neuropathic and inflammatory pain.  (+info)

Integrative approach to the treatment of postherpetic neuralgia: a case series. (7/1061)

OBJECTIVE: To determine if the addition of alternative therapy to conventional medicine enhances the treatment of pain in postherpetic neuralgia (PHN). METHODOLOGY: A review of literature from 1988-1998 was conducted on the MEDLINE database, searching for information on the current treatment of PHN. The literature review found that although many medications have been used to reduce the pain of PHN, no treatments have been completely successful in decreasing pain. Data on pain reduction in PHN following treatment with a multifaceted alternative therapy combined with conventional treatment were compiled from a group of patients in the principal investigator's family medicine practice. RESULTS: The alternative therapy employed in this study, combined with selected medications, showed an average pain reduction of 72.1 percent. There was a 77-percent average pain reduction in patients with herpes zoster (HZ) onset of more than one year and a 68-percent reduction in patients with HZ onset between one month and one year. Almost two-thirds of the 56 PHN patients reported pain reductions of between 75 and 100 percent. CONCLUSION: These preliminary data suggest the combination of alternative therapy and selected conventional medications provides good pain relief for most patients presenting with PHN. Randomized trials with appropriate control groups are needed to validate the effectiveness of this therapy in the treatment of PHN.  (+info)

I. Cellular and molecular biology of sodium channel beta-subunits: therapeutic implications for pain? I. Cellular and molecular biology of sodium channel beta-subunits: therapeutic implications for pain? (8/1061)

Voltage-gated sodium channel alpha-subunits have been shown to be key mediators of the pathophysiology of pain. The present review considers the role of sodium channel auxiliary beta-subunits in channel modulation, channel protein expression levels, and interactions with extracellular matrix and cytoskeletal signaling molecules. Although beta-subunits have not yet been directly implicated in pain mechanisms, their intimate association with and ability to regulate alpha-subunits predicts that they may be a viable target for therapeutic intervention in the future. It is proposed that multifunctional sodium channel beta-subunits provide a critical link between extracellular and intracellular signaling molecules and thus have the ability to fine tune channel activity and electrical excitability.  (+info)

The symptoms of TN can vary in severity and frequency, and may include:

* Pain on one side of the face
* Episodes of sudden, intense pain that can be triggered by light touch or contact with the face
* Pain that is described as stabbing, shooting, or like an electric shock
* Spontaneous pain episodes without any apparent cause
* Pain that is worse with light sensation, such as from wind, cold, or touch
* Pain that is better with pressing or rubbing the affected area

The exact cause of TN is not known, but it is believed to be related to compression or irritation of the trigeminal nerve. The condition can be caused by a variety of factors, including:

* A blood vessel pressing on the nerve
* A tumor or cyst in the brain or face
* Multiple sclerosis or other conditions that damage the nerve
* Injury to the nerve
* Genetic mutations that affect the nerve

There is no cure for TN, but various treatments can help manage the symptoms. These may include:

* Medications such as anticonvulsants or pain relievers
* Nerve blocks or injections to reduce inflammation and relieve pain
* Surgery to decompress the nerve or remove a tumor or cyst
* Lifestyle modifications, such as avoiding triggers and using gentle, soothing touch

It is important for individuals with TN to work closely with their healthcare provider to find the most effective treatment plan for their specific needs. With proper management, many people with TN are able to experience significant relief from their symptoms and improve their quality of life.

A severe and persistent pain disorder that occurs after a herpes zoster (shingles) infection. It is characterized by episodes of intense burning or stabbing pain along the path of the former rash, often accompanied by allodynia (pain from light touch), hyperalgesia (increased sensitivity to pain), and paresthesias (abnormal sensations such as numbness, tingling, or crawling). Postherpetic neuralgia is caused by damage to nerve fibers during the shingles infection and can be difficult to treat.

Pain management strategies for postherpetic neuralgia may include medications such as analgesics, anticonvulsants, and antidepressants; alternative therapies such as acupuncture and transcutaneous electrical nerve stimulation (TENS); and lifestyle modifications such as avoiding triggers that exacerbate the pain.

Neuralgia is often difficult to diagnose and treat, as the underlying cause can be challenging to identify. However, various medications and therapies can help manage the pain and other symptoms associated with this condition. These may include pain relievers, anticonvulsants, antidepressants, and muscle relaxants, as well as alternative therapies such as acupuncture or physical therapy.

Some common forms of neuralgia include:

1. Trigeminal neuralgia: This is a condition that affects the trigeminal nerve, which carries sensation from the face to the brain. It is characterized by sudden, intense pain in the face, typically on one side.
2. Postherpetic neuralgia (PHN): This is a condition that occurs after a shingles infection, and is characterized by persistent pain in the affected area.
3. Occipital neuralgia: This is a condition that affects the nerves in the back of the head and neck, and can cause pain in the back of the head, neck, and face.
4. Geniculate neuralgia: This is a rare condition that affects the nerves in the jaw and ear, and can cause pain in the jaw, face, and ear.

Overall, neuralgia is a complex and debilitating condition that can significantly impact an individual's quality of life. It is important for individuals experiencing symptoms of neuralgia to seek medical attention to determine the underlying cause and develop an appropriate treatment plan.

The condition is caused by damage to the nerves that control facial movements and sensation, often due to injury, surgery, or certain medical conditions such as Bell's palsy or trigeminal neuralgia. It can also be a symptom of other conditions such as multiple sclerosis, Lyme disease, or peripheral neuropathy.

Facial neuralgia can manifest in different ways, including:

* Pain on one side of the face
* Pain that is triggered by specific stimuli such as wind, cold weather, or hot drinks
* Pain that is constant and does not resolve
* Pain that is intermittent and comes and goes
* Pain that is described as stabbing, burning, or aching

The pain can be severe enough to disrupt daily activities and impact quality of life. Treatment options for facial neuralgia depend on the underlying cause and may include medications such as anticonvulsants, antidepressants, or pain relievers, as well as surgical interventions in some cases.

In summary, facial neuralgia is a chronic pain condition that affects the nerves controlling facial expressions and sensation, causing episodes of severe pain in the face that can be triggered by various factors. It can have a significant impact on daily life and requires proper diagnosis and treatment to manage the symptoms.

Types of Glossopharyngeal Nerve Diseases:

1. Glossopharyngeal Neuralgia: This is a condition characterized by recurring episodes of sudden, severe pain in the tongue, throat, and ears. The pain can be triggered by coughing, swallowing, or other movements.
2. Glossopharyngeal Nerve Palsy: This is a condition where the glossopharyngeal nerve is damaged, leading to weakness or paralysis of the tongue and other muscles in the throat and mouth.
3. Glossopharyngeal Fibrillation: This is a condition characterized by rapid, involuntary contractions of the muscles in the throat, which can cause difficulty swallowing and other symptoms.

Causes of Glossopharyngeal Nerve Diseases:

1. Trauma to the head or neck
2. Viral infections such as herpes zoster (shingles) or Lyme disease
3. Bacterial infections such as meningitis or abscesses
4. Tumors or cysts in the throat or brain
5. Inflammatory conditions such as rheumatoid arthritis or sarcoidosis
6. Genetic disorders such as Charcot-Marie-Tooth disease or other inherited neurological conditions

Symptoms of Glossopharyngeal Nerve Diseases:

1. Pain in the tongue, throat, and ears
2. Weakness or paralysis of the tongue and other muscles in the throat and mouth
3. Difficulty swallowing (dysphagia)
4. Hoarseness or other changes in voice quality
5. Loss of taste sensation
6. Ear pain or hearing loss
7. Fatigue, weakness, or numbness in the face and neck
8. Involuntary movements of the tongue, lips, or jaw (tics)
9. Difficulty articulating speech
10. Coughing or choking on food or liquids.

Diagnosis of Glossopharyngeal Nerve Diseases:

1. Medical history and physical examination
2. Imaging studies such as CT or MRI scans
3. Electromyography (EMG) to test the function of muscles in the throat and face
4. Nerve conduction studies (NCS) to evaluate the function of nerves
5. Biopsy of tissue samples from the throat or neck to rule out other conditions.

Treatment for Glossopharyngeal Nerve Diseases:

1. Medications such as antiviral, antibiotic, or anti-inflammatory drugs
2. Surgery to remove tumors or treat nerve damage
3. Physical therapy to improve swallowing and speaking difficulties
4. Speech therapy to improve communication skills
5. Lifestyle changes such as avoiding irritants, maintaining good oral hygiene, and eating a balanced diet.

Prognosis for Glossopharyngeal Nerve Diseases:

The prognosis for glossopharyngeal nerve diseases varies depending on the underlying cause and severity of the condition. In general, with proper treatment and management, many patients can experience significant improvement in their symptoms and quality of life. However, some patients may experience persistent or recurrent symptoms, and in rare cases, the condition can be life-threatening. Early diagnosis and treatment are essential to achieve the best possible outcomes.

The symptoms of pudendal neuralgia can vary depending on the location and severity of the compression or irritation, but may include:

* Pain in the vulva, vagina, clitoris, penis, scrotum, or perineum
* Burning, aching, or shooting pain
* Pain that is worsened by sitting, sexual activity, or other activities that put pressure on the area
* Pain that is relieved by lying down or applying heat to the area
* Numbness or tingling in the skin of the vulva, vagina, clitoris, penis, scrotum, or perineum
* Difficulty with urination or bowel movements due to pain

The exact cause of pudendal neuralgia is not always known, but it may be related to:

* Inflammation or injury to the pudendal nerve
* Compression of the nerve by a nearby structure, such as a blood vessel or muscle
* Trauma to the pelvic area, such as childbirth or surgery
* Neurological conditions, such as multiple sclerosis or peripheral neuropathy
* Cancer in the pelvic area

There is no cure for pudendal neuralgia, but there are several treatments that may help manage the symptoms. These may include:

* Medications, such as pain relievers, anti-seizure drugs, or antidepressants
* Nerve blocks, which involve injecting a local anesthetic into the nerve to temporarily relieve pain
* Physical therapy, which may help improve mobility and reduce pain
* Surgery, such as decompression of the pudendal nerve or nerve grafting

It is important for individuals with pudendal neuralgia to work closely with their healthcare provider to find a treatment plan that works for them. With proper management, many people are able to experience significant improvement in their symptoms and quality of life.

There are several types of nerve compression syndromes, including:

1. Carpal tunnel syndrome: Compression of the median nerve in the wrist, commonly caused by repetitive motion or injury.
2. Tarsal tunnel syndrome: Compression of the posterior tibial nerve in the ankle, similar to carpal tunnel syndrome but affecting the lower leg.
3. Cubital tunnel syndrome: Compression of the ulnar nerve at the elbow, often caused by repetitive leaning or bending.
4. Thoracic outlet syndrome: Compression of the nerves and blood vessels that pass through the thoracic outlet (the space between the neck and shoulder), often caused by poor posture or injury.
5. Peripheral neuropathy: A broader term for damage to the peripheral nerves, often caused by diabetes, vitamin deficiencies, or other systemic conditions.
6. Meralgia paresthetica: Compression of the lateral femoral cutaneous nerve in the thigh, commonly caused by direct trauma or compression from a tight waistband or clothing.
7. Morton's neuroma: Compression of the plantar digital nerves between the toes, often caused by poorly fitting shoes or repetitive stress on the feet.
8. Neuralgia: A general term for pain or numbness caused by damage or irritation to a nerve, often associated with chronic conditions such as shingles or postherpetic neuralgia.
9. Trigeminal neuralgia: A condition characterized by recurring episodes of sudden, extreme pain in the face, often caused by compression or irritation of the trigeminal nerve.
10. Neuropathic pain: Pain that occurs as a result of damage or dysfunction of the nervous system, often accompanied by other symptoms such as numbness, tingling, or weakness.

* Headaches or migraines
* Dental problems (e.g., toothache, abscess)
* Sinusitis
* Eye problems (e.g., conjunctivitis, styes)
* Infections (e.g., colds, flu)
* Allergies
* Injuries or trauma
* Neurological disorders (e.g., trigeminal neuralgia, Bell's palsy)
* Cancer

The types of facial pain include:

* Constant pain: Pain that is present all the time and does not change in intensity.
* Intermittent pain: Pain that comes and goes and may be triggered by specific activities or stimuli.
* Sharp pain: Pain that is sudden and stabbing.
* Dull pain: Pain that is ongoing and aching.
* Throbbing pain: Pain that is pulsing or beating, often with a rhythmic pattern.

The causes of facial pain can vary depending on the location and severity of the pain. Some common causes include:

* Muscle tension or spasm
* Nerve irritation or compression
* Inflammation or infection
* Injury or trauma to the face
* Neurological disorders (e.g., trigeminal neuralgia, Bell's palsy)
* Dental problems (e.g., toothache, abscess)

The diagnosis of facial pain is based on a combination of medical history, physical examination, and diagnostic tests such as X-rays, CT scans, or MRI scans. Treatment for facial pain depends on the underlying cause and may include medications (e.g., pain relievers, antibiotics), lifestyle changes (e.g., avoiding triggers), or surgical intervention (e.g., to remove a tumor).

Hemifacial spasm is a relatively rare movement disorder that affects one side of the face. It is characterized by involuntary muscle contractions and twitching on half of the face, which can be quite distressing for those who experience it. While there are several possible causes, including nerve compression or brain tumors, the exact cause is often difficult to determine.

One of the most common symptoms of HFS is muscle spasms and twitching on one side of the face, which can be quite pronounced and unpredictable. These spasms can occur in any of the muscles on the affected side, including those around the eyes, mouth, and jaw. In some cases, these spasms can also affect the eyelids, causing them to droop or close involuntarily.

The exact cause of hemifacial spasm is not always clear, but it is believed to be related to nerve compression or irritation of the facial nerve. This nerve runs from the brain down through the face and controls many of the muscles in the face, including those involved in eyelid movement and facial expressions. When this nerve is compressed or irritated, it can cause the muscles on one side of the face to spasm and twitch involuntarily.

There are several possible causes of HFS, including:

* Compression of the facial nerve by a blood vessel or tumor
* Trauma to the face or head
* Inflammatory conditions such as multiple sclerosis or sarcoidosis
* Brain tumors or cysts
* Stroke or other forms of brain damage

Treatment for hemifacial spasm usually involves a combination of medications and other therapies. Botulinum toxin injections are often used to relax the affected muscles and reduce spasms. Medications such as anticonvulsants, muscle relaxants, or anti-anxiety drugs may also be prescribed to help manage symptoms. In some cases, surgery may be necessary to relieve compression on the facial nerve.

In addition to these medical treatments, there are also several self-care techniques that can help manage hemifacial spasm. These include:

* Avoiding triggers such as stress or fatigue
* Applying warm compresses to the affected side of the face
* Practicing relaxation techniques such as deep breathing or meditation
* Using eye exercises to strengthen the muscles around the eyes and improve eyelid function.

It is important to seek medical attention if you are experiencing symptoms of hemifacial spasm, as early diagnosis and treatment can help prevent complications and improve outcomes. With proper management, many people with HFS are able to effectively manage their symptoms and lead normal lives.

The diagnosis is based on a physical examination of the eye and can be confirmed by laboratory tests such as PCR or viral culture. Treatment usually involves antiviral medication to reduce pain and prevent complications, and topical steroids to reduce inflammation. In severe cases, corticosteroid injections may be recommended to reduce swelling and prevent scarring.

Preventive measures include avoiding close contact with people who have chickenpox or shingles, practicing good hygiene such as frequent hand-washing and avoiding sharing personal items like towels or makeup. Vaccination is also recommended to prevent the development of herpes zoster ophthalmicus in people who have previously had chickenpox or shingles.

Prognosis for this condition is generally good if treated promptly, and most people recover completely within a few days to weeks. However, complications can include scarring of the cornea, vision loss, and eye inflammation that can lead to permanent blindness. It is important to seek medical attention immediately if symptoms persist or worsen over time.

The term "hypesthesia" comes from the Greek words "hypo," meaning "under," and "aesthesis," meaning "sensation." It is sometimes used interchangeably with the term "hyperesthesia," which refers to an abnormal increase in sensitivity to sensory stimuli.

Hypesthesia can be caused by a variety of factors, including:

* Neurological disorders such as peripheral neuropathy or multiple sclerosis
* Injury or trauma to the nervous system
* Infections such as Lyme disease or HIV
* Certain medications, such as antidepressants or antipsychotics
* Substance abuse

Symptoms of hypesthesia can vary depending on the individual and the underlying cause, but may include:

* Increased sensitivity to touch, light, or sound
* Exaggerated response to stimuli, such as jumping or startling easily
* Difficulty filtering out background noise or sensory input
* Feeling overwhelmed by sensory inputs

Treatment for hypesthesia depends on the underlying cause and may include:

* Medications to manage pain or inflammation
* Physical therapy to improve sensory integration
* Sensory integration techniques, such as deep breathing or mindfulness exercises
* Avoiding triggers that exacerbate the condition

It is important to note that hypesthesia can be a symptom of an underlying medical condition, and proper diagnosis and treatment are necessary to address any underlying causes. If you suspect you or someone you know may be experiencing hypesthesia, it is important to consult with a healthcare professional for proper evaluation and treatment.

Some common causes of paresthesia include:

1. Nerve compression or entrapment: This can occur when a nerve is pinched or compressed due to injury, tumors, or other conditions.
2. Neurodegenerative diseases: Conditions such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease can cause paresthesia by damaging the nerve cells.
3. Stroke or cerebral vasculitis: A stroke or inflammation of the blood vessels in the brain can cause paresthesia.
4. Migraines: Some people experience paresthesia during a migraine episode.
5. Nutritional deficiencies: Deficiencies in vitamins such as B12 and B6, as well as other nutrients, can cause paresthesia.
6. Infections: Certain infections, such as Lyme disease, can cause paresthesia.
7. Trauma: Physical trauma, such as a fall or a car accident, can cause nerve damage and result in paresthesia.
8. Cancer: Some types of cancer, such as lymphoma, can cause paresthesia by damaging the nerves.
9. Autoimmune disorders: Conditions such as rheumatoid arthritis and lupus can cause paresthesia by attacking the body's own tissues, including the nerves.

Paresthesia can be a symptom of an underlying medical condition, so it is important to see a doctor if you experience persistent or recurring episodes of numbness, tingling, or burning sensations. A thorough examination and diagnostic testing can help determine the cause of the paresthesia and appropriate treatment can be recommended.

Brachial plexus neuritis is a condition that affects the brachial plexus, a network of nerves that runs from the spine down to the shoulder and arm. It occurs when the nerves in this region become inflamed or damaged, leading to pain and weakness in the arm and hand.

The condition can be caused by a variety of factors, including injury, infection, or compression of the nerves. It is more common in young adults and may be associated with certain medical conditions, such as diabetes, thyroid disease, or Lyme disease.

Symptoms of brachial plexus neuritis may include pain, numbness, tingling, and weakness in the arm and hand. The condition can also cause difficulty with gripping or grasping objects, and may affect fine motor skills such as writing or buttoning a shirt.

Treatment for brachial plexus neuritis typically involves physical therapy, pain management, and addressing any underlying medical conditions. In some cases, surgery may be necessary to relieve compression or damage to the nerves. With appropriate treatment, most people with brachial plexus neuritis are able to recover significant function in their arm and hand over time.

The trigeminal nerve is a cranial nerve that carries sensation from the face and head to the brain. Trigeminal nerve diseases are conditions that affect this nerve, leading to a range of symptoms such as pain, numbness, weakness, and difficulty with facial movements.

Types of Trigeminal Nerve Diseases:

1. Trigeminal Neuralgia: This is a chronic pain disorder that affects the trigeminal nerve, causing episodes of sudden, intense pain in the face, particularly around the eye and mouth.
2. Multiple Sclerosis (MS): MS is an autoimmune disease that can damage the trigeminal nerve, leading to pain, numbness, and weakness in the face.
3. Trigeminal Neuropathy: This is a condition where the trigeminal nerve is damaged due to injury, inflammation, or infection, leading to pain, numbness, and tingling in the face.
4. Bell's Palsy: This is a condition that affects the facial nerve, leading to weakness or paralysis of the muscles on one side of the face.
5. Herpes Zoster Oticus: This is a viral infection that affects the nerves in the ear and face, causing pain, numbness, and tingling in the face.

Symptoms of Trigeminal Nerve Diseases:

1. Pain: The most common symptom of trigeminal nerve diseases is pain, which can range from mild to severe and can be described as aching, burning, or electric-like.
2. Numbness or tingling: Patients may experience numbness or tingling sensations in the face, particularly around the eye and mouth.
3. Weakness: Some patients may experience weakness or paralysis of the muscles in the face, which can affect their ability to smile, talk, or eat.
4. Difficulty with facial movements: Trigeminal nerve diseases can cause difficulty with facial movements such as closing the eyes, smiling, or whistling.
5. Drooping eyelid or eyebrow: Some patients may experience drooping of the eyelid or eyebrow, which can be a sign of a more severe condition.
6. Eye problems: Trigeminal nerve diseases can cause eye problems such as double vision, blurred vision, or loss of vision in one eye.
7. Headaches: Patients may experience headaches or migraines due to the pressure or inflammation on the nerve.
8. Fatigue: Trigeminal nerve diseases can cause fatigue and exhaustion, particularly if the patient is experiencing persistent pain or discomfort.

Diagnosis of Trigeminal Nerve Diseases:

1. Medical history and physical examination: A thorough medical history and physical examination are essential to diagnose trigeminal nerve diseases.
2. Imaging studies: Imaging studies such as MRI or CT scans may be ordered to rule out other conditions and visualize the nerve.
3. Nerve conduction studies: Nerve conduction studies can help identify the specific location and extent of the nerve damage.
4. Blood tests: Blood tests may be ordered to check for signs of inflammation or infection.
5. Biopsy: A biopsy may be performed to obtain a tissue sample for further examination.

Treatment of Trigeminal Nerve Diseases:

1. Pain management: Pain management is the primary goal of treatment, and it can be achieved through medications, injections, or nerve blocks.
2. Anticonvulsants: Anticonvulsants may be prescribed to manage pain and prevent seizures.
3. Anti-inflammatory medications: Anti-inflammatory medications may be used to reduce inflammation and swelling.
4. Muscle relaxants: Muscle relaxants may be prescribed to relieve muscle spasms and tension.
5. Physical therapy: Physical therapy can help improve range of motion, strength, and function.
6. Surgery: In some cases, surgery may be necessary to relieve compression or damage to the nerve.

Prevention of Trigeminal Nerve Diseases:

1. Early diagnosis and treatment: Early diagnosis and treatment can help prevent progression of the disease and reduce symptoms.
2. Avoiding triggers: Avoiding triggers such as allergens, infections, or trauma can help prevent the onset of trigeminal nerve diseases.
3. Good oral hygiene: Maintaining good oral hygiene can help prevent infections that can lead to trigeminal nerve damage.
4. Avoiding repetitive motions: Avoiding repetitive motions such as frequent clenching or grinding of the teeth can help prevent nerve damage.
5. Proper body mechanics: Maintaining proper body mechanics and posture can help reduce strain on the nerve.
6. Regular check-ups: Regular check-ups with a healthcare professional can help detect any underlying conditions and prevent complications.

There are several types of headaches, including:

1. Tension headache: This is the most common type of headache and is caused by muscle tension in the neck and scalp.
2. Migraine: This is a severe headache that can cause nausea, vomiting, and sensitivity to light and sound.
3. Sinus headache: This type of headache is caused by inflammation or infection in the sinuses.
4. Cluster headache: This is a rare type of headache that occurs in clusters or cycles and can be very painful.
5. Rebound headache: This type of headache is caused by overuse of pain medication.

Headaches can be treated with a variety of methods, such as:

1. Over-the-counter pain medications, such as acetaminophen or ibuprofen.
2. Prescription medications, such as triptans or ergots, for migraines and other severe headaches.
3. Lifestyle changes, such as stress reduction techniques, regular exercise, and a healthy diet.
4. Alternative therapies, such as acupuncture or massage, which can help relieve tension and pain.
5. Addressing underlying causes, such as sinus infections or allergies, that may be contributing to the headaches.

It is important to seek medical attention if a headache is severe, persistent, or accompanied by other symptoms such as fever, confusion, or weakness. A healthcare professional can diagnose the cause of the headache and recommend appropriate treatment.

Please let me know if there is anything else that I can help with.

Intractable pain can have a significant impact on an individual's quality of life, affecting their ability to perform daily activities, sleep, and overall well-being. Treatment for intractable pain often involves a combination of medications and alternative therapies such as physical therapy, acupuncture, or cognitive behavioral therapy.

Some common symptoms of intractable pain include:

* Chronic and persistent pain that does not respond to treatment
* Pain that is severe and debilitating
* Pain that affects daily activities and quality of life
* Pain that is burning, shooting, stabbing, or cramping in nature
* Pain that is localized to a specific area of the body or widespread
* Pain that is accompanied by other symptoms such as fatigue, anxiety, or depression.

Intractable pain can be caused by a variety of factors, including:

* Nerve damage or nerve damage from injury or disease
* Inflammation or swelling in the body
* Chronic conditions like arthritis, fibromyalgia, or migraines
* Infections such as shingles or Lyme disease
* Cancer or its treatment
* Neurological disorders such as multiple sclerosis or Parkinson's disease.

Managing intractable pain can be challenging and may involve a multidisciplinary approach, including:

* Medications such as pain relievers, anti-inflammatory drugs, or muscle relaxants
* Alternative therapies such as physical therapy, acupuncture, or cognitive behavioral therapy
* Lifestyle changes such as regular exercise, stress management techniques, and a healthy diet
* Interventional procedures such as nerve blocks or spinal cord stimulation.

It is important to work closely with a healthcare provider to find the most effective treatment plan for managing intractable pain. With the right combination of medications and alternative therapies, many people are able to manage their pain and improve their quality of life.

The main symptoms of Lateral Medullary Syndrome include:

1. Weakness or paralysis of the face, tongue, and one side of the body
2. Difficulty speaking and swallowing
3. Numbness or tingling sensation in the face and limbs
4. Double vision or other eye movements
5. Dizziness or vertigo
6. Abnormal posture or gait
7. Decreased reflexes

The causes of Lateral Medullary Syndrome are diverse, including:

1. Trauma to the neck or head
2. Stroke or bleeding in the brain
3. Tumors or cysts in the brainstem
4. Infections such as meningitis or encephalitis
5. Vascular malformations
6. Brain aneurysms
7. Arteriovenous malformations
8. Cavernous malformations
9. Trauma to the spinal cord

The diagnosis of Lateral Medullary Syndrome is based on a combination of clinical findings, imaging studies such as MRI or CT scans, and electrophysiological tests like electromyography (EMG) and nerve conduction studies (NCS). Treatment options for Lateral Medullary Syndrome depend on the underlying cause and may include:

1. Supportive care to manage symptoms such as weakness, numbness, and difficulty speaking or swallowing.
2. Physical therapy to improve motor function and prevent joint contractures.
3. Speech therapy to improve communication and swallowing difficulties.
4. Medications to manage pain, spasticity, and other symptoms.
5. Surgery to relieve compression or repair damaged tissue in the brainstem or spinal cord.
6. Rehabilitation to regain lost function and improve quality of life.

The prognosis for Lateral Medullary Syndrome varies depending on the underlying cause and the severity of the injury. In general, the earlier the diagnosis and treatment, the better the outcome. However, some patients may experience significant residual weakness or disability, and a small number may be at risk for sudden death due to the development of cardiac arrhythmias.

Example sentences:

1. The patient experienced a spasm in their leg while running, causing them to stumble and fall.
2. The doctor diagnosed the patient with muscle spasms caused by dehydration and recommended increased fluids and stretching exercises.
3. The athlete suffered from frequent leg spasms during their training, which affected their performance and required regular massage therapy to relieve the discomfort.

The syndrome is caused by mutations in the HCAR2 gene, which codes for a protein involved in the regulation of pain signals. These mutations lead to an overactive response to light and sound, resulting in intense headaches and sensitivity to light and sound.

SUNCT Syndrome typically affects adults between the ages of 20 and 50, with women being more commonly affected than men. The symptoms of SUNCT can be debilitating and significantly impact an individual's quality of life. Treatment options are limited, but may include medications to reduce headache frequency and severity, as well as lifestyle modifications such as avoiding triggers like light and sound.

In summary, SUNCT Syndrome is a rare and severe neurological disorder that causes recurrent headaches, seizures, and cognitive decline, and is caused by mutations in the HCAR2 gene.

There are several different types of pain, including:

1. Acute pain: This type of pain is sudden and severe, and it usually lasts for a short period of time. It can be caused by injuries, surgery, or other forms of tissue damage.
2. Chronic pain: This type of pain persists over a long period of time, often lasting more than 3 months. It can be caused by conditions such as arthritis, fibromyalgia, or nerve damage.
3. Neuropathic pain: This type of pain results from damage to the nervous system, and it can be characterized by burning, shooting, or stabbing sensations.
4. Visceral pain: This type of pain originates in the internal organs, and it can be difficult to localize.
5. Psychogenic pain: This type of pain is caused by psychological factors such as stress, anxiety, or depression.

The medical field uses a range of methods to assess and manage pain, including:

1. Pain rating scales: These are numerical scales that patients use to rate the intensity of their pain.
2. Pain diaries: These are records that patients keep to track their pain over time.
3. Clinical interviews: Healthcare providers use these to gather information about the patient's pain experience and other relevant symptoms.
4. Physical examination: This can help healthcare providers identify any underlying causes of pain, such as injuries or inflammation.
5. Imaging studies: These can be used to visualize the body and identify any structural abnormalities that may be contributing to the patient's pain.
6. Medications: There are a wide range of medications available to treat pain, including analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), and muscle relaxants.
7. Alternative therapies: These can include acupuncture, massage, and physical therapy.
8. Interventional procedures: These are minimally invasive procedures that can be used to treat pain, such as nerve blocks and spinal cord stimulation.

It is important for healthcare providers to approach pain management with a multi-modal approach, using a combination of these methods to address the physical, emotional, and social aspects of pain. By doing so, they can help improve the patient's quality of life and reduce their suffering.

Under the general heading of neuralgia are trigeminal neuralgia (TN), atypical trigeminal neuralgia (ATN), occipital neuralgia ... Occipital neuralgia, also known as C2 neuralgia, or Arnold's neuralgia, is a medical condition characterized by chronic pain in ... glossopharyngeal neuralgia and postherpetic neuralgia (caused by shingles or herpes). The term neuralgia is also used to refer ... as in intercostal neuralgia, trigeminal neuralgia, and glossopharyngeal neuralgia. ...
"Facial Neuralgia Resources". Trigeminal Neuralgia Resources / Facial Neuralgia Resources. Archived from the original on 8 July ... one of which is atypical trigeminal neuralgia ("trigeminal neuralgia, type 2" or trigeminal neuralgia with concomitant pain), ... Trigeminal neuralgia (TN or TGN), also called Fothergill disease, tic douloureux, or trifacial neuralgia is a long-term pain ... Trigeminal neuralgia at Curlie Trigeminal Neuralgia at NHS Choices (Webarchive template wayback links, Articles with short ...
... is caused by damage to the occipital nerves, which can arise from trauma (usually concussive or cervical), ... Rarely, occipital neuralgia may be a symptom of metastasis of certain cancers to the spine. Among other cranial neuropathies, ... Occipital neuralgia (ON) is a painful condition affecting the posterior head in the distributions of the greater occipital ... Occipital Neuralgia - National Institute of Neurological Disorders and Stroke (Articles with short description, Short ...
... is thought to be due to nerve damage caused by herpes zoster. The damage causes nerves in the affected ... Postherpetic neuralgia (PHN) is neuropathic pain that occurs due to damage to a peripheral nerve caused by the reactivation of ... Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L (March 2011). He L (ed.). "Vaccination for preventing postherpetic neuralgia". The ... Its effect on postherpetic neuralgia is still unknown. The vaccine-made from a weakened form of the varicella-zoster virus-may ...
... is a form of nerve pain (neuralgia) specifically associated with a Shingles (herpes zoster) viral ... Ramsay Hunt syndrome type 2 Postherpetic neuralgia Gilden, D. H; Dueland, A. N; Cohrs, R; Martin, J. R; Kleinschmidt-Demasters ... Segal, Alan Z. (2005). "A Vaccine to Prevent Shingles-treating Post-herpetic Neuralgia in a Pre-herpetic State". Neurology ... Saguil, A; Kane, S; Mercado, M; Lauters, R (2017). "Herpes Zoster and Postherpetic Neuralgia: Prevention and Management". ...
... (ATN), or type 2 trigeminal neuralgia, is a form of trigeminal neuralgia, a disorder of the fifth ... TN "Trigeminal Neuralgia Description / Definition", [US] Facial Pain Association, "TN (Trigeminal Neuralgia) Description / ... ninds.nih.gov/health-information/patient-caregiver-education/fact-sheets/trigeminal-neuralgia-fact-sheet "Trigeminal Neuralgia ... Fortunately, post-herpetic neuralgia is generally treated with medications that are also the first medications tried for ATN, ...
hopeful evidence Health fraud Trigeminal neuralgia Atypical trigeminal neuralgia Bouquot JE, Roberts AM, Person P, Christian J ... Neuralgia-inducing cavitational osteonecrosis (NICO) is a controversial diagnosis whereby a putative jawbone cavitation causes ... Bouquot JE, Christian J (April 1995). "Long-term effects of jawbone curettage on the pain of facial neuralgia". J. Oral ... Also called Ratner's bone cavity, a neuralgia-inducing cavitational osteonecrosis was first described in dental literature by G ...
... neuralgia; and involvement of at least one internal organ such as the liver, lung, or heart; d) develops in individuals with ...
Pudendal neuralgia can be caused by many factors including inflammation, extreme cycling, and can be a "secondary condition to ... The term pudendal neuralgia (PN) is often used interchangeably with "pudendal nerve entrapment". This condition can greatly ... Labat JJ, Riant T, Robert R, Amarenco G, Lefaucheur JP, Rigaud J (2008). "Diagnostic criteria for pudendal neuralgia by ... Pulsed radiofrequency has also been successful in treating a refractory case of pudendal neuralgia, but additional research is ...
Trigeminal neuralgia. Méthode du traitement des fractures, Paris, 1916. WorldCat Search Traité de chirurgie clinique et ...
Berlin, 1898.) Trigeminal neuralgia. (Allbutt's System of Medicine, 1899, 6, 724-752.) Herpes zoster. (Allbutt's System of ...
"Trigeminal Neuralgia." In: Rakel RE (ed), Conn's Current Therapy. WB Saunders Co, Phila, PA, pp 900-902, 1996. Bederson JB. " ... trigeminal neuralgia, tumors of the skull base, carotid artery disease and problems of the cervical and lumbar spine. During ...
Bruyn, G. W. (1983-12-01). "Superior Laryngeal Neuralgia". Cephalalgia. 3 (4): 235-240. doi:10.1046/j.1468-2982.1983.0304235.x ...
"Facial Neuralgia Resources". Trigeminal Neuralgia Resources / Facial Neuralgia Resources. Retrieved 8 May 2013. "😱 Face ... A patient resource group for trigeminal neuralgia (which has been described as the most painful condition in existence) have ...
... or geniculate neuralgia (GN), also called nervus intermedius neuralgia, Ramsay Hunt syndrome, or Hunt's ... "Nervus intermedius neuralgia: a case report". CRANIO: The Journal of Craniomandibular Practice. 25. 2007. Saers, S. J. F.; Han ... GN may also occur in combination with trigeminal or glossopharyngeal neuralgia. The pain of GN is sharp, shooting or burning ... Lovely, T. J.; Jannetta, P. J. (1997-07-01). "Surgical management of geniculate neuralgia". The American Journal of Otology. 18 ...
"Pundendal Neuralgia - Diagnosis & Treatment". Ainsworth Institute. Retrieved 2022-04-23. {{cite web}}: ,first4= has generic ... pudendal neuralgia, etc.). There are a number of "alternative" therapies that have been offered for pelvic pain based on the ...
Acute pain due to trigeminal neuralgia is usually successfully treated with anticonvulsants such as carbamazepine or phenytoin ... Bayer DB, Stenger TG (November 1979). "Trigeminal neuralgia: an overview". Oral Surgery, Oral Medicine, and Oral Pathology. 48 ... Brisman R (April 1987). "Trigeminal neuralgia and multiple sclerosis". Archives of Neurology. 44 (4): 379-81. doi:10.1001/ ... as well as trigeminal neuralgia, Lhermitte's sign, or dysesthesias. Subacute pain is usually secondary to the disease and can ...
Weigel G and Casey K. Striking Back! The trigeminal neuralgia handbook. Trigeminal Neuralgia Association Press. Gainesville, ... is a neurosurgical procedure used to treat trigeminal neuralgia (along with other cranial nerve neuralgias) a pain syndrome ... Trigeminal neuralgia and trigeminal tic douloureux. In: Lewis D, ed. Practice of Surgery. Hagerstown, MD: WF Prior CO, 1932: ... Patients most likely to benefit from a microvascular decompression have a classic form of trigeminal neuralgia. The diagnosis ...
Towards the end of the war, she is known to have also suffered from severe depression and trigeminal neuralgia. This condition ... What is Trigeminal Neuralgia? TNA Website Meissner 1980, pp. 141, 228, 234. Thacker 2010, p. 298. "Magda Goebbels". Spartacus ...
... is the only medication that is FDA-approved for the treatment of trigeminal neuralgia. The drug is also claimed ... Pino MA (19 January 2017). "Trigeminal Neuralgia: A "Lightning Bolt" of Pain". US Pharmacist. 42: 41-44. Millichap JG (1 March ... Porter NC (2008). "Trigeminal Neuralgia: Surgical Perspective". In Chin LS, Regine WF (eds.). Principles and practice of ... Gambeta E, Chichorro JG, Zamponi GW (January 2020). "Trigeminal Neuralgia: an overview from pathophysiology to pharmacological ...
Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001; Mar 29;344(13):1019; discussion 1021-2 Landau WM ...
Trigeminal neuralgia is another example of a cause of facial pain. Neuralgia refers to pain in the distribution of a nerve (or ... Trigeminal neuralgia has been described as one of the most painful conditions possible. Trigeminal neuralgia and AFP are ... In 2005 researchers proposed a new classification of trigeminal neuralgia which described a type of trigeminal neuralgia where ... "atypical trigeminal neuralgia", "trigeminal neuropathic pain" and "atypical facial neuralgia" as synonyms of AFP. The ICHD-2 ...
... petrosal neuralgia, sphenopalatine neuralgia, vidian neuralgia, Sluder's neuralgia, Sluder's syndrome, and hemicrania ... Trigeminal neuralgia is a unilateral headache syndrome, or "cluster-like" headache. Management for cluster headache is divided ... Harris W.: Neuritis and Neuralgia. p. 307-12. Oxford: Oxford University Press 1926. Bickerstaff E (1959). "The periodic ... who named the disease migrainous neuralgia. Descriptions of CH date to 1745 and probably earlier. The condition was originally ...
Martin, J. P. (28 March 1931). "A case of glossopharyngeal neuralgia". Br Med J. 1 (3664): 533-534. doi:10.1136/bmj.1.3664.533 ...
In people with trigeminal neuralgia, even a light touch to some part of the body-often a tooth or a part of the face-can give ... Through the 1920s and 1930s the term came into steadily wider use, but almost always in the context of neuralgia. Starting in ... The term was first used in this context around 1914 by Hugh T. Patrick, who was writing about trigeminal neuralgia, a condition ... E. H. Beckman (1916). "Observations on the diagnosis and treatment of trifacial neuralgia". Annals of Surgery. 64 (2): 242-247 ...
Post-herpetic neuralgia uncommonly is associated with shingles in the mouth. Unusual complications may occur with intra-oral ... Postherpetic neuralgia, a condition of chronic pain following shingles. Varicella zoster virus (VZV) has a high level of ... Postherpetic neuralgia arises in approximately 20% of people with shingles. A study of 1994 California data found ... Chen N, Li Q, Yang J, Zhou M, Zhou D, He (2014). He L (ed.). "Antiviral treatment for preventing postherpetic neuralgia". ...
The description of neuralgia was made by John Fothergill (1712-1780). In a medical article entitled "Clinical Lecture on Lead ... Cranial nerves Nerve Neuralgia Neuritis Neuropathy DiBonaventura, Marco D.; Sadosky, Alesia; Concialdi, Kristen; Hopps, Markay ... Carbamazepine is most commonly prescribed to treat trigeminal neuralgia due to clinical experience and early clinical trials ... Al-Quliti, Khalid W. (April 2015). "Update on neuropathic pain treatment for trigeminal neuralgia: The pharmacological and ...
Ocular neuropathic pain (corneal neuralgia); rare In October 2009, the FDA, the National Eye Institute (NEI), and the ...
Trigeminal neuralgia Cluster headache Migraine Wallenberg syndrome (lateral medullary syndrome) is a clinical demonstration of ... Kontzialis M, Kocak M (2017). "Imaging evaluation of trigeminal neuralgia". Journal of Istanbul University Faculty of Dentistry ... part 1 and part 2 on YouTube Trigeminal neuralgia (Articles with short description, Short description is different from ...
"Midol ad for Headache--Neuralgia, Toothache". Archived from the original on 2010-06-20. Retrieved 2010-07-03. "Midol for ...
Occipital neuralgia is a rare neurological condition that involves shooting, shocking, throbbing, burning, or aching pain and ... What is occipital neuralgia?. Occipital neuralgia is a rare neurological condition that involves shooting, shocking, throbbing ... How can I or a loved one help improve care for people with occipital neuralgia?. Consider participating in a clinical trial so ... Where can I find more information about occipital neuralgia?. Information may be available through the following resource: ...
When other diseases cause TN, it is called "secondary trigeminal neuralgia." Causes of secondary trigeminal neuralgia include: ... Trigeminal neuralgia may be caused by a blood vessel (artery or vein) pressing on the trigeminal nerve. This pressure causes ... Treatment for trigeminal neuralgia starts with medications. When medications are not sufficient to control the pain or when a ... Trigeminal neuralgia (TN), also called tic douloureux, is a chronic pain condition that affects the trigeminal nerve. This ...
Clinical resource with information about Amyotrophic neuralgia and its clinical features, SEPTIN9, available genetic tests from ... Amyotrophic neuralgia. Synonyms. Amyotrophy, hereditary neuralgic; Amyotrophy, hereditary neuralgic, with predilection for ...
Trigeminal neuralgia (TN or tic douloureux) causes extreme, sudden burning or shock-like pain in the face. Learn about the ... Trigeminal Neuralgia (Mayo Foundation for Medical Education and Research) * Trigeminal Neuralgia (National Institute of Dental ... Trigeminal neuralgia (TN) is a type of chronic pain that affects your face. It causes extreme, sudden burning or shock-like ... Trigeminal Neuralgia (National Institute of Neurological Disorders and Stroke) Also in Spanish ...
... such as postherpetic neuralgia.[1,3,4] The anticonvulsants gabapentin and pregabalin are other first-line options.[3] ... Because the pain of postherpetic neuralgia is typically continuous in nature, a long-acting opioid (such as sustained-release ... and Drug Administration-approved and is considered a first-line analgesic agent for the treatment of postherpetic neuralgia.[3, ... pain associated with acute herpes zoster but are unlikely to relieve the persistent neuropathic pain of postherpetic neuralgia ...
encoded search term (Postherpetic Neuralgia) and Postherpetic Neuralgia What to Read Next on Medscape ... Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. ... Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics. 2009 Oct. 6(4):630-7. [QxMD MEDLINE Link]. ... A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 2. 352(22):2271-84. [QxMD ...
Postherpetic neuralgia (post-hur-PET-ik noo-RAL-juh) is the most common complication of shingles. It causes a burning pain in ... People with postherpetic neuralgia can develop other problems that are common with long-term pain. It depends on how long the ... Postherpetic neuralgia happens if nerve fibers get damaged during an outbreak of shingles. Damaged fibers cant send messages ... Not being able to stand light touch. People with postherpetic neuralgia often cant bear even the touch of clothing on the ...
EXTRA STRENGTH POSTHERPETIC NEURALGIA CARE- lidocaine hcl cream. To receive this label RSS feed. Copy the URL below and paste ... EXTRA STRENGTH POSTHERPETIC NEURALGIA CARE- lidocaine hcl cream. If this SPL contains inactivated NDCs listed by the FDA ... EXTRA STRENGTH POSTHERPETIC NEURALGIA CARE- lidocaine hcl cream. Number of versions: 1. ...
Trigeminal neuralgia is an uncommon disorder characterized by recurrent attacks of lancinating pain in the trigeminal nerve ... Trigeminal neuralgia: a diagnostic challenge. Jackson EM, Bussard GM, Hoard MA, Edlich RF. Jackson EM, et al. Am J Emerg Med. ... Trigeminal Neuralgia: Current Approaches and Emerging Interventions. Xu R, Xie ME, Jackson CM. Xu R, et al. J Pain Res. 2021 ... Trigeminal neuralgia and other facial pain--diagnosis and therapy]. Siegfried J. Siegfried J. Ther Umsch. 1997 Feb;54(2):83-6. ...
Posts about facial neuralgia written by Andy Wade ... last 5 weeks I have struggled with a bout of facial neuralgia ... Filed under: Health, Lent 2013, life, Pain & tragedy, Rhythms of life, spirituality , Tagged: Christine Sine, facial neuralgia ...
Home Wellness Pain after Shingles â€" How to Manage Postherpetic Neuralgia. Wellness Pain after Shingles â€" How to Manage ... Post-herpatic neuralgia, a chronic painful condition can result after a shingles outbreak. Proper information can be helpful to ... Due to damage to nerve fibers caused by shingles, post hepatic neuralgia can last long after blisters and rashes are gone. The ... Those over 60 are more likely to experience post herpatic neuralgia. People with face or torso outbreaks or chronic illness ...
Top 25 Cited Gamma Knife® Surgery Articles - Trigeminal Neuralgia You are looking at 1 - 1 of 1 items for * Refine by Access: ... Object. The authors sought to evaluate the initial response of trigeminal neuralgia (TN) to gamma knife surgery (GKS) based on ... Gamma knife surgery for trigeminal neuralgia: improved initial response with two isocenters and increasing dose ... Trigeminal Neuralgia Top 25 Cited Gamma Knife® Surgery Articles - Volume 111 Deep Brain Stimulation Best of 2017 Best of 2016 ...
What is Trigeminal Neuralgia?. Trigeminal neuralgia is the most common facial pain syndrome and is often described as "the most ... Trigeminal neuralgia is the most frequently occurring nerve pain disorder. Trigeminal neuralgia is also called tic douloreux ... Order Your Copy of the Medifocus Guidebook on Trigeminal Neuralgia Today!. The Medifocus Guidebook on Trigeminal Neuralgia (131 ... Get the Medifocus Guidebook on Trigeminal Neuralgia.... at a Special 20% Discount. Updated: January 26, 2023. 131 Pages ...
Trigeminal Neuralgia Treated With Stereotactic Radiosurgery: The Effect of Dose Escalation on Pain Control and Treatment ...
Microvascular Decompression for Trigeminal Neuralgia: A Prospective, Multicenter Study.. Mizobuchi Y, Nagahiro S, Kondo A, ... Microvascular decompression (MVD) is the most effective procedure for the long-term management of trigeminal neuralgia (TGN). ...
Zussman, Benjamin M. and Moshel, Yaron A. (2012) "Trigeminal Neuralgia: Case Report and Review," JHN Journal: Vol. 7: Iss. 2, ... and she was diagnosed with trigeminal neuralgia. ... and she was diagnosed with trigeminal neuralgia. ...
Block Trigeminal Neuralgiasphenopalatine ganglion NeuralgiaTMDtmjtmj the great impostertrigeminal nervetrigeminal neuralgia ... Trigeminal Neuralgia: Sphenopalatine Ganglion Block Treatment I recently saw a physician who came in to learn how to do nasal ... Trigeminal Neuralgia: Safest First Line Treatment may be Most Effective Treatment * DNA and RNA Appliances: Vivos Appliance ... SPG Blocks for Trigeminal Neuralgia. * Intra-oral Sphenopalatine Ganglion Block for Pain Control After Nasal Surgery. Sinus ...
... are two minimally invasive techniques for treating trigeminal neuralgia (TN). They were both described over thirty years ago, ... Balloon Compression versus Percutaneous Retrogasserian Glycerol Rhizotomy for the Treatment of Trigeminal Neuralgia. ...
Salman Khan Once Suffered With Trigeminal Neuralgia Disease ... Salman Khan Suffered With Trigeminal Neuralgia Disease: ఐదు ...
Whether or not such treatment influences the subsequent development of postherpetic neuralgia (PHN) has been the subject of ... Whether or not such treatment influences the subsequent development of postherpetic neuralgia (PHN) has been the subject of ...
This is a case of 43 year old woman that presented with general Zia. Did you left medical scape epidermal tumor compressing the trigeminal nerve. This is a challenging location for any approach and we decided to do a minimal invasive Indonesia approach to remove the tumor and relieve her symptoms. We started the operation harvesting an acceptable thought. We then found the median nerve on the left side which gives us access to our surgical window, which is lateral to the left, para Clavel carotid artery right into the front of Michaels cape. We open the dura and found this very classic Y dish, a vascular tumor that was progressively removed after initial developing will gain access to michaels cave itself and form a corridor formed by that connects our opening with the posterior fossa and the cerebellum. We progressively removed this fairly wide two More. You can see the surveil folio in the back and the frustration with a very flattened trigeminal nerve that express explains their symptoms. ...
Trigeminal neuralgia and glossopharyngeal neuralgia. Neurol Clin. 2004. 22: 185-206. 12. Rushton JG, Stevens JC, Miller RH. ... Five patients showed right-sided neuralgia (33%) and 10 patients showed left-sided neuralgia (67%). In this series, 14 of 15 ... This can lead to hyperexcitation and to clinical symptoms of glossopharyngeal neuralgia (GN), which is a very rare entity in ... Patients with glossopharyngeal neuralgia (GN) resulting from neurovascular compression (NVC) were studied. ...
Healed From Pudendal Neuralgia (and lots of other things). Discussion in Success Stories Subforum started by Sparta, Jan 9, ...
... Aneeta Prem TN The most Painful condition. Face Pain CEO TNA UK. suicide disease face pain ... Aneeta Prem Media, Trigeminal neuralgia Aneeta, aneeta prem, TNA uk, Trigeminal neuralgia 0 comments ... Trigeminal Neuralgia Trigeminal neuralgia is the most painful condition in the world. ... Global Sustainable Development Congress Trigeminal Neuralgia & The Cold Leave a Reply Cancel reply. Your email address will not ...
Postherpetic neuralgia (PHN). PHN is the most common complication of herpes zoster. PHN is pain that persists in the area where ...
Tag: neuralgia. Steroid Shots in my Head… The Desperation continued.. I used to do shit like this, just desperate for relief. ...
These statements have not been evaluated by the Food and Drug Administration. No statement contained herein shall be construed as offering these products for the diagnosis, cure, mitigation, treatment, or prevention of any disease. Homeopathic claims are based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated ...
Glossopharyngeal Neuralgia. Glossopharyngeal neuralgia is a rare pain condition affecting the glossopharyngeal nerve, which is ... Carpal Tunnel Syndrome Glossopharyngeal Neuralgia Hemifacial Spasm Peroneal Nerve Syndrome Thoracic Outlet Syndrome Trigeminal ... Glossopharyngeal neuralgia can be caused by pressure on the glossopharyngeal nerve that helps control sensory, parasympathetic ... Diagnosis of a glossopharyngeal neuralgia starts with a physical exam and medical history. Other procedures and tests may be ...
  • Trigeminal neuralgia (TN), also called tic douloureux, is a chronic pain condition that affects the trigeminal nerve. (nih.gov)
  • Trigeminal neuralgia may be caused by a blood vessel (artery or vein) pressing on the trigeminal nerve. (nih.gov)
  • Trigeminal neuralgia may also occur because of other underlying diseases. (nih.gov)
  • When other diseases cause TN, it is called "secondary trigeminal neuralgia. (nih.gov)
  • Symptoms of trigeminal neuralgia may differ depending on the type of TN. (nih.gov)
  • Trigeminal neuralgia (TN) is a type of chronic pain that affects your face. (medlineplus.gov)
  • Trigeminal neuralgia is an uncommon disorder characterized by recurrent attacks of lancinating pain in the trigeminal nerve distribution. (nih.gov)
  • Accurate and prompt diagnosis is important because the pain of trigeminal neuralgia can be severe. (nih.gov)
  • Pregabalin for the treatment of trigeminal neuralgia. (nih.gov)
  • Trigeminal Neuralgia: Basic and Clinical Aspects. (nih.gov)
  • Trigeminal neuralgia and other facial pain--diagnosis and therapy]. (nih.gov)
  • Accommodation to Diagnosis of Trigeminal Neuralgia. (nih.gov)
  • The authors sought to evaluate the initial response of trigeminal neuralgia (TN) to gamma knife surgery (GKS) based on the number of shots delivered and radiation dose. (thejns.org)
  • What is Trigeminal Neuralgia? (medifocus.com)
  • Trigeminal neuralgia is characterized by a sudden (paroxysmal) attack of facial pain described as intense, sharp, like an electric-shock, or stabbing. (medifocus.com)
  • Trigeminal neuralgia is the most frequently occurring nerve pain disorder. (medifocus.com)
  • Trigeminal neuralgia is also called tic douloreux because there is a characteristic muscle spasm that typically accompanies a pain attack. (medifocus.com)
  • Patients with trigeminal neuralgia report that the intermittent pain attacks and the anticipatory anxiety from not knowing when they will occur result in a significant deterioration of their quality of life and interfere with daily activities such as eating and sleeping. (medifocus.com)
  • Trigeminal neuralgia most often affects the maxillary branch or the mandibular branch of the trigeminal nerve. (medifocus.com)
  • Trigeminal neuralgia is considered by the National Organization of Rare Diseases (NORD) to be a rare condition that affects approximately 1.7 million people in the U.S., although estimates vary widely. (medifocus.com)
  • It is estimated by some studies that approximately 4-5 in 100,000 people develop trigeminal neuralgia each year in the United States. (medifocus.com)
  • Other estimates report that approximately 14,000 people in the U.S. develop trigeminal neuralgia each year. (medifocus.com)
  • The incidence of trigeminal neuralgia gradually increases with age. (medifocus.com)
  • Almost twice as many women are affected by trigeminal neuralgia as men. (medifocus.com)
  • If you or a loved one has been diagnosed with trigeminal neuralgia, it's critical to learn everything you possibly can about this condition so that you can make informed decisions about your treatment. (medifocus.com)
  • That's why we created the Medifocus Guidebook on Trigeminal Neuralgia , a comprehensive 131 page patient Guidebook that contains vital information about trigeminal neuralgia that you won't find anywhere in a single source. (medifocus.com)
  • The underlying causes of trigeminal neuralgia. (medifocus.com)
  • The risk factors that can increase a person's chances for developing trigeminal neuralgia. (medifocus.com)
  • The triggers that can precipitate an acute attack of trigeminal neuralgia in many patients. (medifocus.com)
  • The signs and symptoms associated with trigeminal neuralgia. (medifocus.com)
  • A list of other underlying conditions that can cause severe facial pain and may be confused with trigeminal neuralgia that must be taken into consideration in the differential diagnosis of trigeminal neuralgia. (medifocus.com)
  • How trigeminal neuralgia is diagnosed based on factors such as signs/symptoms, patient history, physical examination, dental examination, and imaging studies. (medifocus.com)
  • Treating the underlying cause of trigeminal neuralgia in cases where an underlying cause has been identified. (medifocus.com)
  • To analyze the effect of dose escalation on treatment outcome in patients undergoing stereotactic radiosurgery (SRS) for trigeminal neuralgia (TN). (nih.gov)
  • Microvascular Decompression for Trigeminal Neuralgia: A Prospective, Multicenter Study. (iasp-pain.org)
  • Microvascular decompression (MVD) is the most effective procedure for the long-term management of trigeminal neuralgia (TGN). (iasp-pain.org)
  • Her brain magnetic resonance imaging (MRI) showed no masses or gross abnormalities, and she was diagnosed with trigeminal neuralgia. (jefferson.edu)
  • I brought him in and administered an SPG Block with lidocaine and it relieved his trigeminal Neuralgia Symptoms. (sleepandhealth.com)
  • Percutaneous balloon compression (PBC) and percutaneous retrogasserian glycerol rhizotomy (PRGR) are two minimally invasive techniques for treating trigeminal neuralgia (TN). (cns.org)
  • 10 11 12 ] This can lead to hyperexcitation and to clinical symptoms of glossopharyngeal neuralgia (GN), which is a very rare entity in comparison to trigeminal neuralgia and hemifacial spasm. (surgicalneurologyint.com)
  • Trigeminal neuralgia is the most painful condition in the world. (aneeta.com)
  • For me , a Trigeminal neuralgia attack feels like hundreds of electric shocks, suddenly attacking my face. (aneeta.com)
  • A painful chronic condition that affects this nerve is termed Trigeminal Neuralgia. (avedaayur.com)
  • To provide aid in managing this condition, Life Aveda has designed the Trigeminal Neuralgia Relief Pack which provides Ayurvedic solutions to treat the condition. (avedaayur.com)
  • Aids in managing Trigeminal Neuralgia. (avedaayur.com)
  • Standardized extracts of Brahmi are used in the making of these capsules that naturally help in managing painful sensations caused by Trigeminal Neuralgia. (avedaayur.com)
  • Helps reduce facial pain due to trigeminal neuralgia. (avedaayur.com)
  • Ashwagandha is considered a neuropathic medication and a nerve tonic which is why it works magically in managing neurological conditions such as Trigeminal Neuralgia. (avedaayur.com)
  • Helps in managing neurological conditions such as Trigeminal Neuralgia. (avedaayur.com)
  • The facial pain syndrome known as trigeminal neuralgia was described more than 300 years ago 1) . (operativeneurosurgery.com)
  • see Trigeminal neuralgia epidemiology . (operativeneurosurgery.com)
  • see Trigeminal neuralgia pathogenesis . (operativeneurosurgery.com)
  • Typical trigeminal neuralgia caused by microvascular compression of the trigeminal nerve root in the posterior fossa may become transformed over time into atypical trigeminal neuralgia, if left untreated. (operativeneurosurgery.com)
  • If the theory of progressive change in character of pain and degree of sensory impairment in the course of otherwise typical trigeminal neuralgia is correct, trigeminal neuralgia, atypical neuralgia, and trigeminal neuropathic pain may represent different degrees of injury to the trigeminal nerve, therefore comprising a continuous spectrum rather than discrete diagnoses 2) . (operativeneurosurgery.com)
  • Commentary: Development and Evaluation of a Preoperative Trigeminal Neuralgia Scoring System to Predict Long-Term Outcome Following Microvascular Decompression. (operativeneurosurgery.com)
  • see Trigeminal neuralgia outcome . (operativeneurosurgery.com)
  • see Trigeminal neuralgia case series . (operativeneurosurgery.com)
  • see Trigeminal neuralgia case reports . (operativeneurosurgery.com)
  • Lewy FH: The first authentic case of major trigeminal neuralgia and some comments on the history of this disease. (operativeneurosurgery.com)
  • On the natural history of trigeminal neuralgia. (operativeneurosurgery.com)
  • Introduction: Trigeminal neuralgia (TN) is defined as sudden, usually unilateral, severe and brief pain episodes within the distribution of one or more branches of the trigeminal nerve. (bvsalud.org)
  • In some patients a constant background pain may persist, additionally to pain attacks, which can make difficult to differentiate the trigeminal neuralgia from other orofacial pain types. (bvsalud.org)
  • Objective: To review the classification, physiopathological aspects, epidemiologic data and pharmacological options to control pain related to trigeminal neuralgia. (bvsalud.org)
  • Carbamazepine is the first-line drug, but other anticonvulsants may be employed and have shown variable efficacy in the treatment of trigeminal neuralgia. (bvsalud.org)
  • Conclusion: According to the new classification of the International Headache Society, classic trigeminal neuralgia is divided in purely paroxysmal and with concomitant persistent facial pain. (bvsalud.org)
  • The pathophysiology is unclear, but trigeminal neuralgia seems to be the consequence of vascular compression of the trigeminal nerve near the brain stem. (bvsalud.org)
  • Although TN presents a low prevalence in general population (i.e. 5-30 new patients per 100,000), trigeminal neuralgia is an important clinical concern both by pain severity and difficulty of its satisfactory control. (bvsalud.org)
  • This helps to explain why the SSRIs are effective in relieving depression but not particularly effective in relieving pain, and why the antidepressants with more norepinephrine-selective activity, such as the TCAs and SNRIs, are recommended as first-line analgesics for the treatment of neuropathic pain syndromes, such as postherpetic neuralgia. (medscape.com)
  • The topical lidocaine patch 5% is US Food and Drug Administration-approved and is considered a first-line analgesic agent for the treatment of postherpetic neuralgia. (medscape.com)
  • [ 4 ] Because the pain of postherpetic neuralgia is typically continuous in nature, a long-acting opioid (such as sustained-release morphine or controlled-release oxycodone) is indicated. (medscape.com)
  • [ 5 ] NSAIDs can be helpful in reducing the pain associated with acute herpes zoster but are unlikely to relieve the persistent neuropathic pain of postherpetic neuralgia and are not listed as options in neuropathic pain treatment guidelines. (medscape.com)
  • This condition is known as postherpetic neuralgia (PHN). (medscape.com)
  • Some patients with postherpetic neuralgia (PHN) appear to have abnormal function of unmyelinated nociceptors and sensory loss (usually minimal). (medscape.com)
  • Postherpetic neuralgia is not fatal. (medscape.com)
  • Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. (medscape.com)
  • Postherpetic neuralgia: from preclinical models to the clinic. (medscape.com)
  • Postherpetic neuralgia (post-hur-PET-ik noo-RAL-juh) is the most common complication of shingles. (mayoclinic.org)
  • The risk of postherpetic neuralgia rises with age. (mayoclinic.org)
  • For most people, postherpetic neuralgia gets better over time. (mayoclinic.org)
  • In general, the symptoms of postherpetic neuralgia are limited to the area of skin where the shingles outbreak first happened. (mayoclinic.org)
  • People with postherpetic neuralgia often can't bear even the touch of clothing on the affected skin. (mayoclinic.org)
  • Less often, postherpetic neuralgia can cause an itchy feeling or numbness. (mayoclinic.org)
  • The risk of postherpetic neuralgia becomes lower if you start taking virus-fighting medicines called antivirals within 72 hours of getting the shingles rash. (mayoclinic.org)
  • Postherpetic neuralgia happens if nerve fibers get damaged during an outbreak of shingles. (mayoclinic.org)
  • People with postherpetic neuralgia can develop other problems that are common with long-term pain. (mayoclinic.org)
  • It depends on how long the postherpetic neuralgia lasts and how painful it is. (mayoclinic.org)
  • Shingles vaccines can help prevent shingles and postherpetic neuralgia. (mayoclinic.org)
  • With two doses, Shingrix is more than 90% effective in preventing shingles and postherpetic neuralgia. (mayoclinic.org)
  • Talk to your provider for more information on how well they prevent shingles and postherpetic neuralgia. (mayoclinic.org)
  • Acyclovir and postherpetic neuralgia. (ox.ac.uk)
  • Whether or not such treatment influences the subsequent development of postherpetic neuralgia (PHN) has been the subject of recent controversy. (ox.ac.uk)
  • Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. (bvs.br)
  • Diagnosis of occipital neuralgia is usually done through a physical and neurological exam, along with diagnostic imaging. (nih.gov)
  • Diagnosis of a glossopharyngeal neuralgia starts with a physical exam and medical history. (goodmancampbell.com)
  • For the last 5 weeks I have struggled with a bout of facial neuralgia that has slowed me down physically, mentally and even spiritually. (wordpress.com)
  • Post-herpatic neuralgia, a chronic painful condition can result after a shingles outbreak. (healthstatus.com)
  • Due to damage to nerve fibers caused by shingles, post hepatic neuralgia can last long after blisters and rashes are gone. (healthstatus.com)
  • A vaccine has been approved for those over 60, even those who have already experienced shingles.the vaccine has been shown to prevent both shingles and neuralgia. (healthstatus.com)
  • Qual o melhor tratamento para neuralgia pós-herpética? (bvs.br)
  • Patients with glossopharyngeal neuralgia (GN) resulting from neurovascular compression (NVC) were studied. (surgicalneurologyint.com)
  • Consideramos neuralgia pós-herpética a dor que persiste por mais de 6 semanas após as erupções da herpes zoster. (bvs.br)
  • Tanrikulu L, Hastreiter P, Arnd Dörfler, Buchfelder M, Naraghi R. Classification of neurovascular compression in glossopharyngeal neuralgia: Three-dimensional visualization of the glossopharyngeal nerve. (surgicalneurologyint.com)
  • Glossopharyngeal neuralgia is a rare pain condition affecting the glossopharyngeal nerve, which is deep in the neck. (goodmancampbell.com)
  • Glossopharyngeal neuralgia can be caused by pressure on the glossopharyngeal nerve that helps control sensory, parasympathetic and motor functions. (goodmancampbell.com)
  • Occipital neuralgia is a rare neurological condition that involves shooting, shocking, throbbing, burning, or aching pain and headache that generally starts at the base of the head and spreads along the scalp on one or both sides of the head. (nih.gov)
  • Consider participating in a clinical trial so clinicians and scientists can learn more about occipital neuralgia and head and neck pain. (nih.gov)
  • Learn about clinical trials currently looking for people with occipital neuralgia at Clinicaltrials.gov . (nih.gov)
  • How can I or a loved one help improve care for people with occipital neuralgia? (nih.gov)
  • Where can I find more information about occipital neuralgia? (nih.gov)
  • Trigeminal neuralgia (TN), also called tic douloureux, is a chronic pain condition that affects the trigeminal nerve. (nih.gov)
  • Trigeminal neuralgia may be caused by a blood vessel (artery or vein) pressing on the trigeminal nerve. (nih.gov)
  • Trigeminal neuralgia may also occur because of other underlying diseases. (nih.gov)
  • When other diseases cause TN, it is called "secondary trigeminal neuralgia. (nih.gov)
  • Symptoms of trigeminal neuralgia may differ depending on the type of TN. (nih.gov)
  • The Molecular Basis and Pathophysiology of Trigeminal Neuralgia. (nih.gov)
  • Trigeminal Neuralgia Secondary to Meckel's Cave Meningoencephaloceles: A Systematic Review and Illustrative Case. (nih.gov)
  • Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia. (nih.gov)
  • Correlation study between multiplanar reconstruction trigeminal nerve angulation and trigeminal neuralgia. (nih.gov)
  • Postherpetic neuralgia and trigeminal neuralgia are the two most common forms of neuralgia. (medlineplus.gov)
  • Other causes of facial pain than trigeminal neuralgia (TN) are excluded by history, physical examination, and special investigations (when necessary). (medscape.com)
  • Migraine and cluster headaches may produce severe unilateral pain, but unlike trigeminal neuralgia, these conditions are not triggered by movement or contact with the face nor do they respond promptly to carbamazepine. (medscape.com)
  • Temporomandibular joint pain and dental problems in the evaluation of trigeminal neuralgia. (medscape.com)
  • Thus, the distribution easily distinguishes it from trigeminal neuralgia. (medscape.com)
  • According to Goadsby and Lipton, similar to trigeminal neuralgia, paroxysmal hemicrania syndromes typically last only seconds, however, the latter syndromes occur in and around 1 eye. (medscape.com)
  • Symptomatic or secondary trigeminal neuralgia is a more likely consideration than the idiopathic form when pain is associated with hyperesthesia along the course of the fifth nerve or is observed with other cranial neuropathies. (medscape.com)
  • Trigeminal neuralgia (TN) is characterized by sudden, severe, brief, and stabbing recurrent episodes of facial pain in one or more branches of the trigeminal nerve. (nih.gov)
  • What is trigeminal neuralgia? (nih.gov)
  • Trigeminal neuralgia (TN), also known as tic douloureux, is a type of chronic pain disorder that involves sudden, severe facial pain. (nih.gov)
  • It's possible for you to have both forms of trigeminal neuralgia, sometimes at the same time. (nih.gov)
  • Who is more likely to get trigeminal neuralgia? (nih.gov)
  • How is trigeminal neuralgia diagnosed and treated? (nih.gov)
  • Introduction: Trigeminal neuralgia (TN) is defined as sudden, usually unilateral, severe and brief pain episodes within the distribution of one or more branches of the trigeminal nerve. (bvsalud.org)
  • In some patients a constant background pain may persist, additionally to pain attacks, which can make difficult to differentiate the trigeminal neuralgia from other orofacial pain types. (bvsalud.org)
  • Objective: To review the classification, physiopathological aspects, epidemiologic data and pharmacological options to control pain related to trigeminal neuralgia. (bvsalud.org)
  • Carbamazepine is the first-line drug, but other anticonvulsants may be employed and have shown variable efficacy in the treatment of trigeminal neuralgia. (bvsalud.org)
  • Conclusion: According to the new classification of the International Headache Society, classic trigeminal neuralgia is divided in purely paroxysmal and with concomitant persistent facial pain. (bvsalud.org)
  • The pathophysiology is unclear, but trigeminal neuralgia seems to be the consequence of vascular compression of the trigeminal nerve near the brain stem. (bvsalud.org)
  • Although TN presents a low prevalence in general population (i.e. 5-30 new patients per 100,000), trigeminal neuralgia is an important clinical concern both by pain severity and difficulty of its satisfactory control. (bvsalud.org)
  • The effectiveness of onabotulinumtoxinA (BTX-A) has been established in primary trigeminal neuralgia (TN). (medscape.com)
  • This study aimed to investigate the efficacy of BTX-A treatment in patients with multiple sclerosis-related trigeminal neuralgia (TN-MS) and compare the efficacy of BTX-A treatment between patients with primary trigeminal neuralgia (TN-P) and patients with TN-MS. (medscape.com)
  • Trigeminal neuralgia (TN) is a disorder characterized by recurrent, brief electric shock-like pain in one or more divisions of the trigeminal nerve. (medscape.com)
  • Damage to this nerve can cause trigeminal neuralgia , a clinical condition that can also present in patients with coronavirus disease 2019 (COVID-19). (bvsalud.org)
  • This meta-analysis reviews the clinical cases of trigeminal neuralgia reported in patients with COVID-19 from 2019 to 2022, describes the anatomical mechanism of pain and its radiation and identifies other associated symptoms. (bvsalud.org)
  • We performed a literature search to identify reports of patients with COVID-19 who developed trigeminal neuralgia and examined these cases for prevalence and any identified source of associated ocular pain . (bvsalud.org)
  • Trigeminal neuralgia developed infrequently in patients with COVID-19, and cases with known causes of ocular pain were more common than cases with unknown causes. (bvsalud.org)
  • Understanding the link between COVID-19 and trigeminal neuralgia may lead to preventing further complications and mortality in these patients , as well as improving care for patients with these conditions in the future . (bvsalud.org)
  • What Relieves Postherpetic Neuralgia in the Elderly? (medscape.com)
  • Postherpetic neuralgia (PHN) is a significant issue for elders who experience outbreaks of herpes zoster, commonly referred to as "shingles. (medscape.com)
  • Postherpetic neuralgia (PHN) is the name of the pain that persists even after the shingles rash subsides. (medscape.com)
  • Such pain is called postherpetic neuralgia, which means nerve pain after herpes. (msdmanuals.com)
  • Exactly why postherpetic neuralgia occurs is not well-understood. (msdmanuals.com)
  • Postherpetic neuralgia occurs most often in older people. (msdmanuals.com)
  • As people age, the chance of developing postherpetic neuralgia increases. (msdmanuals.com)
  • The pain of postherpetic neuralgia occurs in the area where the shingles rash occurred. (msdmanuals.com)
  • Postherpetic neuralgia diagnosis is usually based on symptoms and results of a physical examination in people who have had shingles. (msdmanuals.com)
  • Although a number of treatments for severe postherpetic neuralgia have been tried, no treatment is routinely successful. (msdmanuals.com)
  • Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. (bvs.br)
  • Other syndromes with paroxysmal lancinating head pain include the less common glossopharyngeal neuralgia and occipital neuralgia syndromes. (medscape.com)
  • Occipital neuralgia causes pain in the posterior head region. (medscape.com)
  • What is occipital neuralgia? (nih.gov)
  • Occipital neuralgia is a rare neurological condition that involves shooting, shocking, throbbing, burning, or aching pain and headache that generally starts at the base of the head and spreads along the scalp on one or both sides of the head. (nih.gov)
  • Diagnosis of occipital neuralgia is usually done through a physical and neurological exam, along with diagnostic imaging. (nih.gov)
  • How can I or a loved one help improve care for people with occipital neuralgia? (nih.gov)
  • Consider participating in a clinical trial so clinicians and scientists can learn more about occipital neuralgia and head and neck pain. (nih.gov)
  • Learn about clinical trials currently looking for people with occipital neuralgia at Clinicaltrials.gov . (nih.gov)
  • Where can I find more information about occipital neuralgia? (nih.gov)
  • A related but less common neuralgia affects the glossopharyngeal nerve , which provides feeling to the throat. (medlineplus.gov)
  • Glossopharyngeal neuralgia causes pain in the tonsillar fossa, posterior pharynx, and ear and may be initiated by coughing, yawning, or swallowing cold liquids. (medscape.com)
  • El daño a este nervio puede causar neuralgia del trigémino , una condición clínica que también puede presentarse en pacientes con enfermedad por coronavirus 2019 ( COVID-19 ). (bvsalud.org)
  • Este metaanálisis revisa los casos clínicos de neuralgia del trigémino informados en pacientes con COVID-19 desde 2019 hasta 2022, describe el mecanismo anatómico del dolor y su radiación e identifica otros síntomas asociados. (bvsalud.org)
  • Realizamos una búsqueda bibliográfica para identificar informes de pacientes con COVID-19 que desarrollaron neuralgia del trigémino y examinamos estos casos en busca de prevalencia y cualquier fuente identificada de dolor ocular asociado. (bvsalud.org)
  • La neuralgia del trigémino se desarrolló con poca frecuencia en pacientes con COVID-19 , y los casos con causas conocidas de dolor ocular fueron más comunes que los casos con causas desconocidas. (bvsalud.org)
  • Comprender el vínculo entre COVID-19 y la neuralgia del trigémino puede ayudar a prevenir más complicaciones y mortalidad en estos pacientes , así como a mejorar la atención de los pacientes con estas afecciones en el futuro. (bvsalud.org)
  • Consideramos neuralgia pós-herpética a dor que persiste por mais de 6 semanas após as erupções da herpes zoster. (bvs.br)
  • Neuralgia is more common in older people, but it may occur at any age. (medlineplus.gov)
  • In Raeder syndrome (paratrigeminal neuralgia), ophthalmoparesis is present. (medscape.com)